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angina vs acute coronary syndrome (2.1±2.8% vs 0.7±0.8%, p=0.0331). In diabetic pts,
%total segment fibrotic plaque (41±7% vs 29±14%, p=0.0286) and %lipid core (19±5%
vs 11±8%, p=0.0099) were larger vs non-diabetics. Importantly, %total segment lipid
core decreased with increasing HLD (r=0.44, p=0.0063), but there was no correlation
with LDL (Figure). Conclusions: VH affords real-time assessment of plaque histopathol-
ogy (not just grey scale images) that has been correlated to human necropsy specimens.
This information will reveal important correlations with clinical disease states. 
1006-57 Atherosclerotic Plaque Can Be Quantified Using 
Multifractal and Wavelet Decomposition Techniques
Liberty O. Yaneza, Robert J. Chilton, Edmund K. Kerut, Dimitrios Charalampidis, Dwight 
Chrisman, Michael S. Lujan, Carlos Leon Alviar, Thomas D. Giles, Robert A. O’Rourke, 
University of Texas Health Science Center, San Antonio, TX, State University Health 
Sciences Center, New Orleans, LA
Introduction:
Classification of plaque morphology into soft, fibrocalcific and calcific by intravascular
ultrasound (IVUS) is done by comparing plaque intensity to surrounding adventitia. How-
ever, this technique is subject to bias and to inherent limitation of IVUS machine.Texture
analysis is a form of tissue characterization based on the distribution of ultrasound ampli-
tude signals within a region-of-interest (ROI). Two methods, the wavelet decomposition
and multifractal techniques are currently being utilized to quantify image texture.
Methodology:
IVUS images performed from year 2000-2002 at the Cardiac Catheterization Laboratory
of South Texas Veterans Health Care Systems, San Antonio, Texas were analysed.
These images were exported into Desktop computer and analyzed after placing a 16 x
16 ROI box. Mean and standard deviation of pixel intensity values were generated.
Quantitation of ROI texture using 2 methods were performed by generation of multifractal
exponents, and normalized detail coefficients using wavelet decomposition method.
Results: 
Seventy three images were analysed. The overall intensity and energy generated by dif-
ferent plaque morphologies were significantly higher in calcific lesions as compared to
soft plaque. Furthermore, a significant association is also noted with different plaque
morphologies and texture analysis using both multifractal and wavelet decomposition
method. The values generated with texture analysis using multifractal exponents are
higher in calcific plaques as compared to soft lesions (0.539 +0.03 vs 0.504 +0.04, P
0.001).However, with wavelet decomposition method, the normalized detail coefficients
were significantly lower in calcific lesions (0.004 +0.01 vs 0.008 +0.00, P 0.006).
Conclusion:
A significant association was noted between plaque morphologies and texture analysis
using both wavelet decomposition and multifractal techniques. Using these techniques,
standard normalized values may be generated to classify plaques into truly calcific, fibro-
calcific and soft lesions. Additionally, these data may create values in further classifying
soft plaques into predominantly lipid, thrombus or necrotic degeneration.
1006-58 The Relation Between the Statin’s Effects on Coronary 
Plaque Composition and Plasma Low-Density 
Lipoprotein Cholesterol Level Evaluated by 
Intravascular Ultrasound Radiofrequency Signal 
Analysis
Masaki Yokoyama, Brian K. Courtney, Takashi Nakayama, Susumu Namikawa, Mizuo 
Nameki, Issei Komuro, Nobuyuki Komiyama, Chiba University Graduate School, Chiba, 
Japan, Stanford University Medical Center, Palo Alto, CA
Background: Many large trials reported that statins could reduce coronary events in pri-
mary and secondary prevention as well as plasma low-density lipoprotein cholesterol
(LDL) levels. Intravascular ultrasound radio-frequency signal (IVUS-RF) parameters such
as integrated backscatter (IB) have been shown to be useful in discriminating histological
components in human coronary plaques. We already reported that administration of sta-
tin for 6 months could clinically increase IB in human coronary plaques. In this study, we
sought to evaluate the relation between the plasma LDL levels and coronary plaque com-
position in a manner clinically detectable by IVUS-RF analysis.
Methods: Consecutive 20 patients undergoing percutaneous coronary intervention (PCI)
with plasma total cholesterol (TC) level between 180 and 230 mg / dl were investigated.
We searched for echo-lucent plaques in non-PCI-influenced coronary regions using a 40
MHz IVUS catheter after PCI and acquired IVUS-RF signals. The patients began to take
atorvastatin 10 mg / day after PCI procedure. At 6-month follow-up, plasma lipid levels
were measured in each patient and IVUS-RF signals were sampled at the same plaque
sites. Several regions of interest (ROIs) were placed on each plaque. IB was measured in
all ROIs blindly to the LDL data. Total of 148 ROIs were analyzed and %LDL change
(baseline LDL – follow-up LDL / baseline LDL x 100 (%)) was calculated in each patient.
Results: Plasma LDL level was significantly reduced from 133 ± 13 to 87 ± 29 mg / dl (p
< 0.0001) during the 6-month follow-up. IB was substantially increased from – 53.8 ± 4.5
to – 51.2 ± 4.9 dB (p < 0.0001). Increase of IB at the ROIs (n = 88) in patients with %LDL
change >= 40 % was significantly greater than at the ROIs (n = 60) in patients with %
LDL change < 40 % (3.79 ± 4.8 vs. 0.70 ± 3.6 dB; p< 0.0001), however, increase of IB
was not different between patients with LDL < 100 mg / dl and LDL >= 100 mg / dl at the
follow-up.
Conclusions: These results suggest that statin may alter acoustic properties of coronary
plaques and the effect of statin on plaque composition may not be related to the value of
LDL cholesterol at the end point but the amount of its reduction.
1006-59 Angioscopic Findings in Patients With Non-ST Elevation 
Acute Coronary Syndromes According to Troponin T 
Status
Kentaro Okamatsu, Kyoichi Mizuno, Shunta Sakai, Fumiyuki Ishibashi, Masamichi 
Takano, Nippon Medical School, Chiba Hokusoh Hospital, Chiba, Japan
Background It has been reported that troponin T could help improve the effectiveness of
such antithrombotic drugs as platelet glicoprotein IIb/IIIa antagonists in patients with non-
ST elevation acute coronary syndromes (NSTE-ACS). However, the mechanism remains
unclear. We therefore investigated the relationship between angioscopic lesion charac-
teristics and the troponin T release in NSTE-ACS. 
Methods and Results We studied 57 consecutive NSTE-ACS patients who underwent
angioscopy. Before catheterization, we obtained blood samples to determine troponin
positivity and the patients were classified as a troponin-positive and troponin-negative
group (diagnostic threshold; 0.1ng/ml). With angioscopy before angioplasty, we exam-
ined the presence of coronary thrombus, yellow plaque, and complex plaque. Twenty-two
patients were troponin-positive, and 35 patients were troponin-negative. No significant
differences were seen in the incidence of yellow plaque (77% vs. 83%), in the incidence
of complex plaque (64% vs. 68%) between the two groups. The incidence of coronary
thrombus detected with angioscopy in the troponin-positive group was significantly higher
than that in the troponin-negative group (86% vs. 34%; P=0.0001). Conclusions Using
angioscopy, the elevated troponin T levels in NSTE-ACS were confirmed to be strongly
associated with the presence of coronary thrombus, but not the atheroscrerotic change
of plaque itself. Our finding supports previous studies reported only the antithrombotic
drugs can neutralize the heightened risk of troponin-positive patients with NSTE-ACS.
1006-60 Coronary Arterial Wall Temperature Heterogenity in 
Patients With Acute Coronary Syndrome: An 
Intracoronary Thermography Study
Dariusz Dudek, Jacek Legutko, Lukasz Rzeszutko, Angela Richter, Marcin Wizimirski, 
Jacek S. Dubiel, Jagiellonian University, Krakow, Poland
Background: Increase of vessel wall temperature in patients with acute coronary syn-
drome (ACS) has been previously reported. The aim of this study was to assess the
safety and accuracy of intracoronary vessel wall temperature measurements in patients
with ACS using new catheter based, flow non-limiting thermography system.
Methods: We performed intracoronary thermography in 23 patients (pts) (mean age
54±10 years) with ACS (13 pts with acute myocardial infarction within 12 hours of chest
pain onset, 10 pts with unstable angina within 48 hours of the last chest pain) with TIMI 3
flow in the culprit artery before the procedure. We used 3.5-F thermography catheter
containing a self-expanding basket with 5 arms and a thermocouple on each arm mea-
suring vessel wall temperature, as well as a central thermocouple measuring blood tem-
perature, allowing detection of differences of 0.05ºC. Thermography was performed
before PCI of the culprit lesion. In all studied vessels we assessed blood temperature
(Tbl, ºC) and the maximum temperature difference between blood and any thermal cou-
ple (∆Tmax, ºC) during pullback (0.5mm/s).
Results: There were no device-related adverse effects or system failures. Mean Tbl was
36.7±0.7ºC and mean ∆Tmax was 0.093±0.032ºC. Temperature difference was higher in
the culprit segment in comparison to non culprit segment of the vessel (∆Tmax =
0.12±0.03 vs. 0.07±0.008, p<0,001). In one case, a focal 0.18ºC temperature peak was
recorded at the culprit lesion. In 6 pts thermography catheter stopped the flow during
thermal mapping when catheter was in a severely stenotic lesion. Tbl increased on aver-
age 0.2±0.07 with no flow at culprit segment, but it was paralleled by the increase in the
vessel wall temperature, so ∆Tmax remained unchanged.
Conclusions: Intracoronary thermography in patients with ACS was safe and able to
detect heterogeneous arterial wall temperature within the culprit vessel. Temperature
heterogeneity was higher in the culprit that in non culprit segment of the vessel.
1006-61 Coronary Lesion Temperature Measurement During 
Transient Blood Flow Occlusion Using a Novel Thermal 
Sensing System
Jorge A. Belardi, Fernando Cura, Lucio Padilla, Oscar Mendiz, Joseph Korotko, William 
O'Neill, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
Background: Temperature measurement of coronary arteries may provide lesion assess-
ment beyond conventional angiography and ultrasound imaging. It holds the potential to
be a predictor of future clinical events. However, studies have shown that blood flow
through an artery interferes with the ability to measure lesion temperature.
Methods: We performed the first in man application of a novel thermal sensing catheter
(Accumed Systems Inc, Ann Harbor, Mi) that temporarely occludes flow through the
artery to make temperature measurement in patients before undergoing elective percuta-
neous coronary intervention. On the distal portion of the catheter is an expandable braid
that is mounted on a pair of nested plastic tubes with three thermistors attached to the
exterior surface of the sleeve. The system takes a baseline reading of blood temperature
flowing through the artery and then surface temperature of the lesion while blood flow is
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occluded for 30-60 seconds. The measurement is the difference between these two read-
ings.
Results: Temperature measurements were made in 15 lesions from 11 patients with a
mean age of 62 years, 90% male, 36% diabetes and 82% with acute coronary syn-
dromes. Measurement were made in all three major coronary arteries. The mean tem-
perature elevation was 0.4 (range 0-2.2oC). Five of the 15 lesions had a mean
temperature elevation of 0.9 oC (range 0.3-2.2) over baseline while the rest of lesions
(n=10) had no temperature change from baseline. No complications were observed with
its clinical application. Conclusion: A thermal sensing catheter that temporarely occludes
flow during the measurement is a safe and feasible means to accurately measure lesion
temperature. The system used in this trial holds promise as a new diagnostic tool to
guide treatment of coronary lesions.
1006-62 Forward Looking Optical Coherence Tomography: A 
Potential Tool to Visualize the Total Chronic Occlusion
Johannes A. Schaar, Evelyn Regar, Frits Mastik, Anton F. van der Steen, Patrick W. 
Serruys, Erasmus Medical Center, Rotterdam, The Netherlands, Interuniversity 
Cardiology Institute of the Netherlands, Utrecht, The Netherlands
PCI of chronic total occlusion is technically challenging. The direct visualization of the
occlusion could help to steer the guidewire and increase the safety and success rate of
recanalization procedures. Intravascular Optical Coherence Tomography (OCT) is a new
light emitting technique, which provides high resolution cross-sectional images of the
vessel wall (~ 15 microns). We hypothesised that OCT is suitable to give forward-looking
information on vessel anatomy.
An OCT catheter (Lightlab Inc) was modified to emit near infrared (1340nm) light in an
angle of 30° from the axis of the catheter. The catheter is rotating around his axis provid-
ing a cone like beam providing images of structures that are located in front of the cathe-
ter.
Forward looking OCT was performed in a cryogel (PVA 5%) phantom, which mimics the
anatomy of an artery with a total occlusion by introducing the modified catheter into the
phantom and advancing the catheter. After image acquisition the phantom was cut open
and the morphology was assessed (figure 1).
It was feasible with OCT to detect the total occlusion, the geometry and the size of the
phantom. The surface of the occlusion was clearly delineated. Details of the vessel mim-
icking phantom wall were clearly visible. Comparison with the structure of the phantom
showed remarkable agreement between images and details of the vessel wall and the
occlusion.
Forward looking OCT is feasible in-vitro and may provide valuable in-vivo information for
recanalization of chronic total occlusions.
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1024-47 Sirolimus Versus Plain Old Balloon Angioplasty Small 
Vessels
David R. Holmes, Jr., Jeffrey Moses, Martin Leon, Mark Midei, Michael Mooney, Donald 
Baim, Samuel DeMaio, Jeffrey Popma, Richard Kuntz, The SIRIUS Trial Investigators, 
Mayo Clinic, Rochester, MN
Background: Results of stenting in smaller vessels compared with angioplasty alone
have been variable and conflicting particularly in regards to restenosis prevention and fol-
low up events. The Sirolimus-eluting stent may improve the outcome in these vessels.
Purpose: In vessels < 3mm to evaluate effectiveness of the Sirolimus-eluting Bx velocity
stent in the randomized SIRIUS Trial and compare it to patients treated in BENESTENT I
+ II and STRESS with conventional PTCA.
Population: 370 lesions treated with Sirolimus-eluting stent in the SIRIUS Trial and 437
lesions treated with PTCA alone in BENESTENT I (n=120), BENESTENT II (n=209) and
STRESS (n=108). All patients had treatment of de novo lesions in vessels with RVD <
3.0mm
Results: Sirolimus stent patients were at higher risk;
1) The mean reference RVD was 2.56±0.28 in Sirolimus versus 2.65±0.24mm in the
PTCA group
2) Lesion length in Sirolimus was significantly longer 14.0±5.8 versus 7.9±2.6mm
3) Diabetes was more frequent 27% in Sirolimus versus 12.1% in PTCA Group
Despite these higher risk characteristics, patients treated with Sirolimus had improved
outcome at 270 days (table)
>Conclusions: Implantation of Sirolimus-eluting stents in small vessels < 3.0mm results
in markedly improved outcome compared with conventional PTCA alone.
1024-48 Intraprocedural Stent Thrombosis: A Potentially New 
Emerging Complication With Usage of Long Stents in 
the Drug-Eluting Stent Era
Alaide Chieffo, Erminio Bonizzoni, Dejan Orlic, Renata Rogacka, Flavio Airoldi, Matteo 
Montorfano, Nicola Corvaja, Ghada W Michail, Antonio Colombo, San Raffaele Hospital, 
Milan, Italy, EMO Centro Cuore Columbus, Milan, Italy
Background Intraprocedural stent thrombosis (IPST) is an unheard event outside spe-
cific settings such as acute myocardial infarction, thrombus containing lesions or dissec-
tions. Some concerns have been raised due to the implantation of long stent required by
sirolimus-eluting stents (SES). The aim of our study was to investigate the frequency and
the predictors of IPST in drug-eluting stent era. 
Methods and Results Between April 2002 and August 2003, 683 patients (pts) were
treated with Cypher (Cordis, Johnson and Johnson Company, Warren, NJ) Sirolimus-
Eluting Stent (SES) implantation in San Raffaele Hospital and EMO Centro Cuore
Columbus. 146 (21%) patients were diabetics,161 (23%) had unstable angina. 239pts
(35%) were pretreated with glycoprotein IIb/IIIa inhibitors (IIb/IIIa). Maximum stent length
per vessel (per patient) was 43.2±28.4mm. IPST occurred in 5 (0.7%) patients. None of
the patients with IPST was pretreated with IIb/IIIa Multivariate analysis using exact test
for logistic regression modelling showed that maximum stent length per vessel (exact
odds ratio [OR]=1.039 , 95% confidence interval [CI]= 1.016-1.067; p=0.001) and the
lack of use of elective IIb/IIIa (OR=11.6,CI=1.5 -∝,p=0.016) were independent correlates
of IPST.
Conclusions Stent length and no pretreatment with IIb/IIIa are independently correlated
with occurrence of IPST. Particular attention will need to be paid to this new emerging
complication when long stents are being used. 
1024-49 Impact of Sirolimus-Eluting Stents on the Outcome of 
Patients With Chronic Total Occlusions: Multicenter 
Registry in Asia
Sunao Nakamura, Tamil S. Selvan, Jang-Ho Bae, Yeo H. Cahyadi, Orathai Pachirat, New 
Tokyo Hospital, Matsudo, Japan
Background: Although previous clinical studies utilizing sirolimus-eluting stents (SES) in
simple coronary lesions demonstrated an impressive reduction in intimal hyperplasia and
restenosis, long –term efficacy of SES in treating patients with chronic total occlusion is
still unknown. A prospective Asian multicenter registry was set up in 5 high volume Asian
centers to evaluate the efficacy of SES in the treatment of chronic total occlusions.
Method: A total of 88 patients with 102 chronic total occlusions (male 70.5% mean age
69.2) (defined as TIMI flow grade 0 and the age of occlusion was more than 3 months:
LAD=42.1% LCX=27.3% RCA=30.6%) were treated with SES after successful lesion
crossing and dilating the lesions. We evaluate immediate and long-term clinical results by
6 months and 12 months angiography. Results: See table for clinical results. The 12
months QCA results will be available at the time of presentation. Conclusion: These
results showed utilizing the SES can dramatic suppress the restenosis rate with chronic
total occlusive lesions.
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MACE (Any Death, 
MI, TLR)
8.4% (31/370) 24.7% (106/429) -16.3%{-21.3%,-11.4%}
Death 1.1% (4/370) 0.0% (0/429) 1.1% {0.0%, 2.1%}
Any MI 3.0% (11/370) 3.3% (14/429) -0.3% {-2.7%, 2.1%}
Target Lesion 
Revasc




0.3% (1/370) 1.4% (6/429) -1.1% {-2.4%, 01.%)
Number of patients 88
Procedural success (%) 100
MACE at 30 days (%) 0
Reference diameter (mm) 2.86±0.66
MLD post (mm) 2.65±0.55
MLD at 6 months (mm) 2.54±0.44
Restenosis rate (%) 3.4
TVR (%) 4.5
MACE at 6 months (%) 4.5
